Skip to Content

A 139 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint A 139 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Alembic Pharmaceuticals Inc..

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A 139

Fenofibric acid delayed-release 135 mg A 139

Fenofibric Acid Delayed-Release

Imprint
A 139
Strength
135 mg
Color
Blue & Yellow
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Inc.
National Drug Code (NDC)
62332-0245
Inactive Ingredients
hypromelloses, povidone k30, water, hydroxypropyl cellulose (type e), silicon dioxide, sodium stearyl fumarate, methacrylic acid, magnesium silicate, triethyl citrate, gelatin, titanium dioxide, ferric oxide yellow, FD&C Blue No. 2, shellac, propylene glycol, potassium hydroxide, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "A 139"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.